| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | President and CEO, Director | Common Stock | 44,410 | $574,221 | $12.93 | 13 Dec 2024 | Direct |
| PIERIS PHARMACEUTICALS, INC. | President and CEO, Director | Stock Option (right to buy) | 417,806 | 13 Dec 2024 | Direct | ||
| PIERIS PHARMACEUTICALS, INC. | President and CEO, Director | Non-Qualified Stock Option (right to buy) | 243,831 | 05 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PVLA | PALVELLA THERAPEUTICS, INC. | 05 Feb 2025 | 1 | $0 | 4/A | President and CEO, Director | 10 Feb 2025, 18:25 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 13 Dec 2024 | 0 | $0 | 3/A | President & CEO, Director, 10%+ Owner | 06 Jan 2025, 16:59 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 13 Dec 2024 | 1 | $0 | 4 | President and CEO, Director, 10%+ Owner | 17 Dec 2024, 20:41 |